JP2007527417A5 - - Google Patents

Download PDF

Info

Publication number
JP2007527417A5
JP2007527417A5 JP2006541459A JP2006541459A JP2007527417A5 JP 2007527417 A5 JP2007527417 A5 JP 2007527417A5 JP 2006541459 A JP2006541459 A JP 2006541459A JP 2006541459 A JP2006541459 A JP 2006541459A JP 2007527417 A5 JP2007527417 A5 JP 2007527417A5
Authority
JP
Japan
Prior art keywords
alkyl
alkenyl
pharmaceutical formulation
administered
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541459A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007527417A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039716 external-priority patent/WO2005055926A2/en
Publication of JP2007527417A publication Critical patent/JP2007527417A/ja
Publication of JP2007527417A5 publication Critical patent/JP2007527417A5/ja
Pending legal-status Critical Current

Links

JP2006541459A 2003-11-20 2004-11-22 白内障、黄斑変性および他の眼疾患の改善 Pending JP2007527417A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52380303P 2003-11-20 2003-11-20
PCT/US2004/039716 WO2005055926A2 (en) 2003-11-20 2004-11-22 Amelioration of cataracts, macular degeneration and other ophthalmic diseases

Publications (2)

Publication Number Publication Date
JP2007527417A JP2007527417A (ja) 2007-09-27
JP2007527417A5 true JP2007527417A5 (enrdf_load_stackoverflow) 2008-01-17

Family

ID=34676585

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006541459A Pending JP2007527417A (ja) 2003-11-20 2004-11-22 白内障、黄斑変性および他の眼疾患の改善

Country Status (8)

Country Link
EP (1) EP1689354A4 (enrdf_load_stackoverflow)
JP (1) JP2007527417A (enrdf_load_stackoverflow)
KR (1) KR20070040326A (enrdf_load_stackoverflow)
CN (1) CN101102770A (enrdf_load_stackoverflow)
AU (1) AU2004296738A1 (enrdf_load_stackoverflow)
CA (1) CA2546053A1 (enrdf_load_stackoverflow)
IL (1) IL175498A0 (enrdf_load_stackoverflow)
WO (1) WO2005055926A2 (enrdf_load_stackoverflow)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589107B2 (en) 2003-05-19 2009-09-15 Othera Holding, Inc. Amelioration of vitrectomy-induced cataracts
WO2006127592A2 (en) * 2005-05-26 2006-11-30 Othera Pharmaceuticals, Inc. Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
CA2640738A1 (en) * 2006-02-22 2007-09-07 Othera Holding, Inc. Hydroxylamines and derivatives for the inhibition of complement activation
WO2008101195A2 (en) * 2007-02-16 2008-08-21 Othera Holding, Inc. Drug resistance reversal in neoplastic disease
EP2620429A1 (en) * 2007-02-22 2013-07-31 Colby Pharmaceutical Company Hydroxylamine compounds and methods of their use
WO2009070693A2 (en) * 2007-11-28 2009-06-04 Sirion Therapeutics, Inc Modulators of ocular oxidative stress
EP2080513A1 (en) * 2008-01-16 2009-07-22 Schraermeyer, Ulrich, Prof. Dr. rer. nat Tetrahydropyridoethers for treatment of AMD
CN102988331B (zh) * 2012-05-31 2015-02-04 管孝君 2-巯基-3-丁醇用于制备抗晶状体混浊产品的用途
WO2015168347A1 (en) * 2014-04-30 2015-11-05 The Johns Hopkins University Dendrimer compositions and their use in treatment of diseases of the eye
CN115350285A (zh) 2014-08-13 2022-11-18 约翰霍普金斯大学 树枝状聚合物到脑肿瘤的选择性传递
TW201625264A (zh) * 2014-10-31 2016-07-16 學校法人慶應義塾 水晶體硬化抑制劑
WO2018201007A2 (en) 2017-04-27 2018-11-01 The Johns Hopkins University Dendrimer compositions for use in angiography
US20200038355A1 (en) * 2017-04-28 2020-02-06 Case Western Reserve University Antioxidants for use in ophthalmic surgery
CA3082121C (en) 2017-11-10 2023-01-24 The Johns Hopkins University Dendrimer delivery system and methods of use thereof
US11612660B2 (en) 2019-12-04 2023-03-28 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352442A (en) * 1985-07-18 1994-10-04 Proctor Peter H Topical tempo
EP0327263B1 (en) * 1988-01-29 1994-09-07 PROCTOR, Peter H. Hair growth stimulation with nitroxide and other radicals
AU1447095A (en) * 1993-12-30 1995-07-17 Arcturus Pharmaceutical Corporation Methods for the treatment of the central nervous system or eye involving pathogenic oxidation pathways
ATE194596T1 (de) * 1994-11-15 2000-07-15 Moreno Paolini N-hydroxypiperidine als superoxid-radikalfänger
US6001853A (en) * 1996-01-26 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Hydroxylamine compositions for the prevention or retardation of cataracts
DE60138385D1 (de) * 2000-06-29 2009-05-28 Mei Co Ltd Heilmittel zur behandlung von erkrankungen des sehnervs
IT1320080B1 (it) * 2000-10-25 2003-11-18 Giuliani Spa Composizione per uso farmaceutico o dietetico.
BR0310057A (pt) * 2002-05-17 2007-04-10 Othera Pharmaceuticals Inc melhoria do desenvolvimento de catarata e outras doenças oftálmicas

Similar Documents

Publication Publication Date Title
JP2007527417A5 (enrdf_load_stackoverflow)
JP2008531714A (ja) 不安障害の治療用及び／又は予防用の医薬組成物
JP2010536797A5 (enrdf_load_stackoverflow)
JP2011510014A5 (enrdf_load_stackoverflow)
JP2006524185A5 (enrdf_load_stackoverflow)
Khaw Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy
JP2008538741A (ja) 鬱病の治療用及び／又は予防用の医薬組成物
RU2009144142A (ru) Лечение возрастной дегенерации желтого пятна с применением ингибиторов фактора d комплемента
WO2011053792A4 (en) Methods and compositions for sustained delivery of drugs
EA201000441A1 (ru) Водные офтальмологические препараты
RU2014123472A (ru) Производные 4-прегенен-11ss-17-21-триол-3,20-диона для лечения глазных болезней
ES2540151B1 (es) Composición farmacéutica de ibuprofeno y tramadol para uso oftálmico
JP2005509623A5 (enrdf_load_stackoverflow)
JP2017520527A5 (enrdf_load_stackoverflow)
JP2021506971A (ja) イソキサゾリン系寄生虫駆除剤及び眼瞼炎を治療する方法
JP2005527605A5 (enrdf_load_stackoverflow)
RU2431502C2 (ru) Фармацевтические композиции для лечения сухости глаз
BRPI1016257B1 (pt) composições compreendendo finafloxacina para tratamento de infecções óticas
AU2017261303A1 (en) Ophthalmic compositions
Polat et al. Combined phacoemulsification and trabectome for treatment of glaucoma
JP6116714B2 (ja) 眼科炎症疾患治療用点眼剤組成物及びその製造方法
FI2765988T3 (fi) Silmäkoostumus, joka sisältää bromfenaakkia, jolla on parannettu biologinen hyötyosuus
JP2009538827A (ja) カンナビノイドおよび使用方法
RU2020119228A (ru) Соединения, композиции и способы лечения нарушений со стороны органа зрения и заболеваний кожи
Petrov et al. Modern methods of minimally invasive glaucoma surgery